Life Sciences

Pharmaceutical, medical device and biotechnology companies remain under pressure to navigate ever-changing regulations while justifying product value and improving health outcomes.

Featured Insights

  • Biopharmaceutical Firm Increases Efficiency and Global Compliance with a Centralized Risk Management System

    Read More

    To minimize compliance costs and inefficiencies across global teams, one biopharmaceutical firm implemented Orbit, a centralized drug safety commitment platform.

  • The Coming Age for Digital Health: Implications for the Life Sciences Industry

    Read More

    Digital health is critical to reducing costs and better managing data across the care continuum while also improving patient access, compliance and outcomes.

  • Cell and Gene Therapies: The Catalyst for Novel Commercial Strategies

    Read More

    To address disruption to care pathways created by cell and gene therapies, pharmaceutical companies must encourage innovation and improve patient access.

  • Launch Excellence: Why So Elusive?

    Read More

    Product launches are inherently optimistic occasions for companies, representing opportunities to market new products and generate fresh sources of revenue.

View All